These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3260220)

  • 1. Novel 17-kilodalton Leishmania antigen revealed by immunochemical studies of a purified glycoprotein fraction recognized by murine T lymphocytes.
    Rodrigues MM; Xavier MT; Mendonça-Previato L; Barcinski MA
    Infect Immun; 1988 Jul; 56(7):1766-70. PubMed ID: 3260220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cellular immune response to a purified antigen from Leishmania mexicana subsp. amazonensis enhances the size of the leishmanial lesion on susceptible mice.
    Rodrigues MM; Mendonça-Previato L; Charlab R; Barcinski MA
    Infect Immun; 1987 Dec; 55(12):3142-8. PubMed ID: 3500131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of cellular immune response to chemically defined glycoconjugates from Leishmania mexicana subsp. amazonensis.
    Rodrigues MM; Xavier MT; Previato LM; Barcinski MA
    Infect Immun; 1986 Jan; 51(1):80-6. PubMed ID: 2416692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a major 72 kilodalton surface antigen in twelve isolates of Leishmania braziliensis braziliensis.
    Legrand D; Desjeux P; le Pont F; Brénière SF; Lemesre JL; Santoro F; Capron A
    Mol Biochem Parasitol; 1987 Jun; 24(2):117-24. PubMed ID: 3627165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leishmania amazonensis: humoral response to amastigote excreted-antigens in murine leishmaniasis.
    Hernández-Chinea C
    Exp Parasitol; 2007 Aug; 116(4):492-6. PubMed ID: 17349625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of the specificity of seric IgA produced in response to antigens of Leishmania (Leishmania) mexicana in murine leishmaniasis].
    Pérez-Aguilar MC; Hernández O; Maizo de Segnini Z; Rojas CH; Díaz S; Alarcón M; Goncalves L
    Invest Clin; 2011 Sep; 52(3):216-29. PubMed ID: 21950193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection.
    Coelho EA; Tavares CA; Carvalho FA; Chaves KF; Teixeira KN; Rodrigues RC; Charest H; Matlashewski G; Gazzinelli RT; Fernandes AP
    Infect Immun; 2003 Jul; 71(7):3988-94. PubMed ID: 12819086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies specific for the amastigote stage of Leishmania pifanoi. I. Characterization of antigens associated with stage- and species-specific determinants.
    Pan AA; McMahon-Pratt D
    J Immunol; 1988 Apr; 140(7):2406-14. PubMed ID: 2450920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stage-specific glycosphingolipids from amastigote forms of Leishmania (L.) amazonensis. Immunogenicity and role in parasite binding and invasion of macrophages.
    Straus AH; Levery SB; Jasiulionis MG; Salyan ME; Steele SJ; Travassos LR; Hakomori S; Takahashi HK
    J Biol Chem; 1993 Jun; 268(18):13723-30. PubMed ID: 8514804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosphingolipid antigens of Leishmania (Leishmania) amazonensis amastigotes identified by use of a monoclonal antibody.
    Barbiéri CL; Giorgio S; Merjan AJ; Figueiredo EN
    Infect Immun; 1993 May; 61(5):2131-7. PubMed ID: 7683002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and size heterogeneity of a 63 kilodalton membrane glycoprotein during growth and transformation of Leishmania mexicana amazonensis.
    Chang CS; Inserra TJ; Kink JA; Fong D; Chang KP
    Mol Biochem Parasitol; 1986 Feb; 18(2):197-210. PubMed ID: 3515177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with antigenic extracts of Leishmania associated with Montanide ISA 763 adjuvant induces partial protection in BALB/c mice against Leishmania (Leishmania) amazonensis infection.
    Cargnelutti DE; Salomón MC; Celedon V; García Bustos MF; Morea G; Cuello-Carrión FD; Scodeller EA
    J Microbiol Immunol Infect; 2016 Feb; 49(1):24-32. PubMed ID: 24662018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses induced by a Leishmania (Leishmania) amazonensis recombinant antigen in mice and lymphocytes from vaccinated subjects.
    Fernandes AP; Herrera EC; Mayrink W; Gazzinelli RT; Liu WY; de Costa CA; Tavares CA; Melo MN; Michalick MS; Gentz R; Nascimento E
    Rev Inst Med Trop Sao Paulo; 1997; 39(2):71-8. PubMed ID: 9394518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of new Leishmania promastigote surface antigens, LaPSA-38S and LiPSA-50S, as major immunodominant excreted/secreted components of L. amazonensis and L. infantum.
    Bras-Gonçalves R; Petitdidier E; Pagniez J; Veyrier R; Cibrelus P; Cavaleyra M; Maquaire S; Moreaux J; Lemesre JL
    Infect Genet Evol; 2014 Jun; 24():1-14. PubMed ID: 24614507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophil chemotactic activity in Leishmania amazonensis promastigotes.
    Saito S; Hamada A; Watanabe N; Obata T; Katakura K; Ohtomo H
    Parasitol Res; 1996; 82(6):485-9. PubMed ID: 8832727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal vaccination with killed Leishmania amazonensis promastigotes antigen (LaAg) associated with CAF01 adjuvant induces partial protection in BALB/c mice challenged with Leishmania (infantum) chagasi.
    Leal JM; Mosquini M; Covre LP; Stagmiller NP; Rodrigues RR; Christensen D; de Matos Guedes HL; Rossi-Bergmann B; Gomes DC
    Parasitology; 2015 Nov; 142(13):1640-6. PubMed ID: 26394776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell responses to immunodominant LACK antigen do not play a critical role in determining susceptibility of BALB/c mice to Leishmania mexicana.
    Torrentera FA; Glaichenhaus N; Laman JD; Carlier Y
    Infect Immun; 2001 Jan; 69(1):617-21. PubMed ID: 11119565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection.
    Satoskar A; Bluethmann H; Alexander J
    Infect Immun; 1995 Dec; 63(12):4894-9. PubMed ID: 7591152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan.
    Halliday A; Bates PA; Chance ML; Taylor MJ
    Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against Leishmania major in BALB/c mice by adoptive transfer of a T cell clone recognizing a low molecular weight antigen released by promastigotes.
    Scott P; Caspar P; Sher A
    J Immunol; 1990 Feb; 144(3):1075-9. PubMed ID: 2295814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.